Literature DB >> 10663973

C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders.

A Takeda1, M Hashimoto, M Mallory, M Sundsumo, L Hansen, E Masliah.   

Abstract

alpha-Synuclein is a presynaptic terminal protein that accumulates abnormally in plaques in Alzheimer's disease (AD), in Lewy bodies in Lewy body disease (LBD) and in filamentous inclusions in multiple system atrophy. Since it has been previously shown that proteinase K or formic acid pretreatment enhances alpha-synuclein immunoreactivity in Lewy bodies and plaques, we hypothesized that the immunoreactivity in tangles, glial cells and Pick bodies might be revealed by such pretreatment. Brain sections from patients with AD, LBD, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and Pick's disease were pretreated with proteinase K or formic acid and immunostained with antibodies against the N-terminal, C-terminal or non-amyloid beta component of AD amyloid (NAC) regions of alpha-synuclein. This study showed that after proteinase K (but not formic acid) pretreatment the anti-C terminus antibody immunostained neurofibrillary tangles of AD, PSP and CBD, and glial inclusions of PSP and CBD, as well as Pick bodies. Western blot analysis confirmed that in cases other than LBD, the anti-C terminus antibodies also recognized the native alpha-synuclein band and no cross-reactive bands were observed. In contrast, in LBD, after formic acid pretreatment with the anti-NAC antibody astroglial cells and granular neurons were immunostained. The N-terminal region antibody only recognized the lesions in LBD cases and not those of other neurodegenerative disorders. These results support the view that different fragments of alpha-synuclein might play an important role in the pathogenesis of several neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10663973     DOI: 10.1007/pl00007441

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  The role of NAC in amyloidogenesis in Alzheimer's disease.

Authors:  M Hashimoto; T Takenouchi; M Mallory; E Masliah; A Takeda
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

Review 2.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

3.  Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.

Authors:  Thomas G Beach; Charles H Adler; Geidy Serrano; Lucia I Sue; D G Walker; Brittany N Dugger; Holly A Shill; Erika Driver-Dunckley; John N Caviness; Anthony Intorcia; Jessica Filon; Sarah Scott; Angelica Garcia; Brittany Hoffman; Christine M Belden; Kathryn J Davis; Marwan N Sabbagh
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

4.  Insoluble alpha-synuclein in Alzheimer's disease without Lewy body formation.

Authors:  Melissa Broe; Claire E Shepherd; David M A Mann; Elizabeth A Milward; Wei-Ping Gai; Emma Thiel; Glenda M Halliday
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 5.  Inflammation in the early stages of neurodegenerative pathology.

Authors:  Preeti J Khandelwal; Alexander M Herman; Charbel E-H Moussa
Journal:  J Neuroimmunol       Date:  2011-08-05       Impact factor: 3.478

Review 6.  Hemostasis components in cerebral amyloid angiopathy and Alzheimer's disease.

Authors:  Nicole Ziliotto; Francesco Bernardi; Fabrizio Piazza
Journal:  Neurol Sci       Date:  2021-05-27       Impact factor: 3.307

7.  p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy.

Authors:  Yun Ju C Song; Ditte M S Lundvig; Yue Huang; Wei Ping Gai; Peter C Blumbergs; Peter Højrup; Daniel Otzen; Glenda M Halliday; Poul H Jensen
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

8.  Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model.

Authors:  Preeti J Khandelwal; Sonya B Dumanis; Li Rebekah Feng; Kathleen Maguire-Zeiss; Gw Rebeck; Hilal A Lashuel; Charbel Eh Moussa
Journal:  Mol Neurodegener       Date:  2010-11-04       Impact factor: 14.195

9.  CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease.

Authors:  Lumine Matsumoto; Hiroshi Takuma; Akira Tamaoka; Hiroshi Kurisaki; Hidetoshi Date; Shoji Tsuji; Atsushi Iwata
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

10.  Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synuclein.

Authors:  Dora Games; Peter Seubert; Edward Rockenstein; Christina Patrick; Margarita Trejo; Kiren Ubhi; Benjamin Ettle; Majid Ghassemiam; Robin Barbour; Dale Schenk; Silke Nuber; Eliezer Masliah
Journal:  Am J Pathol       Date:  2013-01-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.